Product Categories
| Country: | China |
|---|---|
| Tel: | 025-02557628056 |
| Mobile: | 15150681880 |
| E-mail: | |
| QQ: | |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| Thymalfasin | C129H215N33O55 | 69440-99-9 | Details |
| 4-[4-Bromo-3-(1,3-dioxolan-2-yl)phenoxy]benzonitrile | C16H12BrNO3 | 1217366-74-9 | Details |
| Oxytocin Acetate | C43H66N12O12S2 | 50-56-6 | Details |
| 5nm DMSA coated Fe3O4nanoparticles | Details |
| 50nm PEG-modified magnetic nanoparticles（Amino terminus） | Details |
| Tetraisopropyl methylenediphosphonate | C13H30O6P2 | 1660-95-3 | Details |
| (2R,3S,4S,5S)-5-Hydroxy-2,3,4-tris(phenylmethoxy)-5-[(phenylmethoxy)methyl]-cyclohexanone | C35H36O6 | 115250-38-9 | Details |
| (2S)-(+)Glycidyl-3-nitrobenzene sulfonate | C9H9NO6S | 115314-14-2 | Details |
| 4-(4-Bromo-3-formylphenoxy)benzonitrile | C14H8BrNO2 | 906673-54-9 | Details |
| 4-[4-Bromo-3-[[(tetrahydro-2H-pyran-2-yl)oxy]methyl] phenoxy]benzonitrile | C19H18BrNO3 | 943311-78-2 | Details |
| 2,4-diamino-6-(hydroxymethyl)-pteridine hydrochloride | C7H8N6O.HCl.xH2O | 73978-41-3 | Details |
| 10nm OA coated Fe3O4 nanoparticles（Pyrolysis） | Details |
| 5nm PEG-modified magnetic nanoparticles（Amino terminus） | Details |
| (3R,4R)-3-(3,4-dimethyl-4-piperidiny) phenol | C13H19NO | 119193-19-0 | Details |
| Alvimopan dihydrate | C25H36N2O6 | 170098-38-1 | Details |
| Octreotide Acetate | C49H66N10O10S2 | 83150-76-9 | Details |
| (aR,3aS,4S,6S,7aR)-Hexahydro-3a,8,8-trimethyl-alpha-(2-methylpropyl)-4,6-methano-1,3,2-benzodioxaborole-2-methanamine 2,2,2-trifluoroacetate | C17H29BF3NO4 | 179324-87-9 | Details |
| Ethyl 1H-imidazole-4-carboxylate | C6H8N2O2 | 23785-21-9 | Details |
| 2-(2-Methyl-2H-tetrazol-5-yl)-5-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)pyridine | C13H18BN5O2 | 1056039-83-8 | Details |
| 4-[4-Bromo-3-(hydroxymethyl)phenoxy]benzonitrile | C14H10BrNO2 | 906673-45-8 | Details |
| 6-Nitroquinoxaline-2,3-dione | C8H5N3O4 | 2379-56-8 | Details |
| 5-fluoro-3-phenyl-2-((1S)-1-((9-(tetrahydro-2H-pyran-2-yl)-9H-purin-6-yl) amino)propyl)quinazolin-4(3H)-one | C27H26FN7O2 | 1453810-71-3 | Details |
| 2-methyl-2-(4-(2-(tosyloxy)ethyl)phenyl)propanoate | C20H24O5S | 1181267-30-0 | Details |
| 10nm APTS coated Fe3O4nanoparticles | Details |
| 10nm PEG-modified magnetic nanoparticles（Carboxy terminus） | Details |
| 3-[(3-Amino-4-methylaminobenzoyl)pyridin-2-ylamino]propionic acid ethyl ester | C18H22N4O3 | 212322-56-0 | Details |
| (alphaS,3R,4R)-4-(3-Hydroxyphenyl)-3,4-dimethyl-alpha-(phenylmethyl)-1-piperidinepropanoic acid methyl ester | C24H31NO3 | 170098-29-0 | Details |
| (R)-1-[5-Amino-2-(2-benzyloxy-1,1-dimethyl-ethyl)-6-fluoro-indol-1-yl]-3-benzyloxy-propan-2-ol… | C29H33FN2O3 | 1294504-67-8 | Details |
| (S)-tert-butyl(1-(5-fluoro-4-oxo-3-phenyl-3,4-dihydroquinazolin-2-yl)propyl) carbaMate | C22H24FN3O3 | 870281-85-9 | Details |
| (S)-4-(3-(1-(hexyloxy)ethyl)-2-methoxyphenyl)thiazol-2-amine | C18H26N2O2S | 1110767-98-0 | Details |
| Somatostatin | C76H104N18O19S2 | 51110-01-1 | Details |
| 4-(Hydroxymethyl)imidazole | C4H6N2O | 822-55-9 | Details |
| (R)-(+)-2-Tetrahydrofuroic acid | C5H8O3 | 87392-05-0 | Details |
| 4-(2-Hydroxyethyl)oxyindole | C10H11NO2 | 139122-19-3 | Details |
| 10nm DMSA coated Fe3O4nanoparticles | Details |
| 5nm PEG-modified magnetic nanoparticles（Methoxy terminus） | Details |
| (+)-(1S,4R)-P-MENTHA-2,8-DIEN-1-OL | C10H16O | 22972-51-6 | Details |
| 2-Bromobenzimidazole | C7H5BrN2 | 54624-57-6 | Details |
| 2-(4-Methoxy-1,4-cyclohexadienyl)-2-propanol | C10H16O2 | 61597-37-3 | Details |
| 5-Bromo-2-(2-methyl-2H-tetrazol-5-yl)pyridine | C7H6BrN5 | 380380-64-3 | Details |
| 1-[2-fluoro-6-(trifluoromethyl)benzyl]-5-iodo-6-methylpyrimidine-2,4(1H,3H)-dione | C13H9F4IN2O2 | 1150560-54-5 | Details |
| Trans-(+/-)-11-Chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-dibenz [2,3:6,7]oxepino[4,5-c]pyrrole-1-one | C17H14ClNO2 | 129385-59-7 | Details |
| (S)-2-(1-aMinopropyl)-5-fluoro-3-phenylquinazolin-4(3H)-one | C17H16FN3O | 870281-86-0 | Details |
| 2-Methyl-5-nitrobenzotrifluoride | C8H6F3NO2 | 89976-12-5 | Details |
| (2,4-diaminopteridin-6-yl)methanol | C7H8N6O | 945-24-4 | Details |
| Thymosin beta 4 acetate | C212H350N56O78S | 77591-33-4 | Details |
| 10nm Au nanoparticles | Details |
| 5nm PEG-modified magnetic nanoparticles（Carboxy terminus） | Details |
| 10nm PEG-modified magnetic nanoparticles（Amino terminus） | Details |
| 2,4-diamino-6-(bromomethyl)pteridine | C7H8Br2N6 | 52853-40-4 | Details |
| N-(4-Cyanophenyl)glycine | C9H8N2O2 | 42288-26-6 | Details |
| Teriparatide | C181H291N55O51S2 | 99294-94-7 | Details |
| 4-Hydroxybenzenepropanoic acid [(4S)-2,2-dimethyl-1,3-dioxolan-4-yl]methyl este | C15H20O5 | 144256-11-1 | Details |
| Ticagrelor | C23H28F2N6O4S | 274693-27-5 | Details |
| N-(2-aminoethyl)-4-morpholinecarboxamide oxalate | C9H17N3O6 | 154467-16-0 | Details |
| 2-Bromo-5,6-dimethyl-1H-benzo[d]imidazole | C9H9BrN2 | 1189164-12-2 | Details |
| 20nm APTS coated Fe3O4nanoparticles | Details |
| 20nm PEG-modified magnetic nanoparticles（Carboxy terminus） | Details |
| 1H-Imidazole-4-carboxylic acid | C4H4N2O2 | 1072-84-0 | Details |
| Ganirelix Acetate | C80H113ClN18O13 | 123246-29-7 | Details |
| Dabigatran etexilate | C34H41N7O5 | 211915-06-9 | Details |
| 4-[4-Bromo-3-[(methoxymethoxy)methyl]phenoxy]benzonitrile | C16H14BrNO3 | 947162-14-3 | Details |
| Imidazole-4-carbaldehyde | C4H4N2O | 3034-50-2 | Details |
| Elcatonin | C148H244N42O47 | 60731-46-6 | Details |
| 20nm DMSA coated Fe3O4nanoparticles | Details |
| 10nm PEG-modified magnetic nanoparticles（Methoxy terminus） | Details |
| favipiravir 6-fluoro-3-hydroxypyrazine-2-carboxamide | C5H4FN3O2 | 259793-96-9 | Details |
| 6-Aminoquinoxaline-2,3(1H,4H)-dione | C8H7N3O2 | 6973-93-9 | Details |
| N-[4-(Methylamino)benzoyl]-(L)-Glutamic Acid Diethyl Ester | C16H22N2O5 | 13726-52-8 | Details |
| Methyl 1H-imidazole-5-carboxylate | C5H6N2O2 | 17325-26-7 | Details |
| 3-[[[2-[[(4-Cyanophenyl)amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]pyridin-2-ylamino]propionic acid ethyl ester | C27H26N6O3 | 211915-84-3 | Details |
| N-[3-Fluoro-4-[6-(2-methyl-2H-tetrazol-5-yl)-3-pyridinyl] phenyl] carb amic acid phenylmethyl ester | C21H17FN6O2 | 1220910-89-3 | Details |
| (5R)-3-(4-Bromo-3-fluorophenyl)-5-hydroxymethyloxazolidin-2-one | C10H9BrFNO3 | 444335-16-4 | Details |
| 3,5-Dichloro-4-[(1E)-3-ethoxy-2-methyl-3-oxo-1-propen-1-yl]benzoic acid | C13H12Cl2O4 | 1110767-89-9 | Details |
| Abaloparatide | C174H300N56O49 | 247062-33-5 | Details |
| Thymopentin Acetate(TP-5) | C30H49N9O9 | 69558-55-0 | Details |
| 5nm Au nanoparticles | Details |
| 20nm PEG-modified magnetic nanoparticles（Amino terminus） | Details |
| 50nm PEG-modified magnetic nanoparticles（Methoxy terminus） | Details |
| 2,4,5,6-Tetraaminopyrimidine sulfate | C4H10N6O4S | 5392-28-9 | Details |
| 5-(1,1-Dimethylheptyl)resorcinol | C15H24O2 | 56469-10-4 | Details |
| 2 3-Dichloro-6-nitroquinoxaline | C8H3Cl2N3O2 | 2379-60-4 | Details |
| 2-Bromo-3H-imidazo[4,5-c]pyridine | C6H4BrN3 | 1557344-85-0 | Details |
| 3-Iodo-4-methylbenzoic acid | C8H7IO2 | 82998-57-0 | Details |
| 5nm OA coated Fe3O4 nanoparticles（Pyrolysis） | Details |
| 50nm PEG-modified magnetic nanoparticles（Carboxy terminus） | Details |
| Methotrexate disodium | C20H23N8NaO5 | 7413-34-5 | Details |
| 5,6-Dihydro-1H,4H-naphtho[1,8-cd]pyran-1-one | C12H10O2 | 14935-18-3 | Details |
| Carbetocin | C45H69N11O12S | 37025-55-1 | Details |
| MelanotanⅡ Acetate | C50H69N15O9 | 121062-08-6 | Details |
| 11-chloro-2,3-dihydro-2-methyl-1H-dibenz[2,3;6,7]oxepino[4,5-c]py rrol-1-one | C17H12ClNO2 | 1012884-46-6 | Details |
| Elagolix sodium | C32H29F5N3NaO5 | 832720-36-2 | Details |
| Semaglutide | C187H291N45O59 | 910463-68-2 | Details |
| Bivalirudin | C98H138N24O33 | 128270-60-0 | Details |
| 5nm APTS coated Fe3O4nanoparticles | Details |
| 20nm PEG-modified magnetic nanoparticles（Methoxy terminus） | Details |
| Cetrorelix Acetate | C70H92N17O14 | 130143-01-0 | Details |
| 6-(chloromethyl)pteridine-2,4-diamine monohydrochloride | C7H8Cl2N6 | 82778-08-3 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 | ||||